PSORIATIC ARTHRITISRESEARCH STUDY
Consider your next steps with Psoriatic Arthritis
As you may know, PsA is an autoimmune disease and affects some people who have psoriasis, which is a skin disease that presents as red, scaly rashes most often on the elbows, knees, ankles, feet, and hands. PsA causes the immune system to attack the joints, leading to inflammation. This results in pain, stiffness, and swelling in the joints. Symptoms of PsA can vary from person to person and change locations in the body. It can also affect any joint in the body and could affect just one joint or multiple joints at a time.
Managing PsA is important because without treatment, the condition can lead to joint damage. However, just as the symptoms can vary from person to person, the treatment can also vary. For some patients with PsA. their current treatment is inadequate. Whether you are just starting your journey with PsA or trying to find a different treatment option, you may be considering your next steps. Your participation in clinical trials that focus on PsA may help pave the way to develop more potential treatments for future patients with PsA.
If you have PsA, you may qualify for a research study evaluating a potential new oral medication underway in your area.
You May Qualify if You:
- Were diagnosed to have psoriatic arthritis (PsA) at least 3 months ago
- Have active plaque psoriatic skin lesion(s) or documented medical history of plaque psoriasis
- Have not tried tried biologic disease-modifying anti-rheumatic drugs
Participants May Receive:
- Study-related medical care at no cost
- Study-related medications at no cost
- Reimbursement for time and travel